Kane Biotech Announces new DispersinB® Publication in Pathogens and Conference Presentations
PremiumPress ReleasesKane Biotech Announces new DispersinB® Publication in Pathogens and Conference Presentations
22d ago
Kane Biotech Secures New Qatar Distribution Deal
Premium
Company Announcements
Kane Biotech Secures New Qatar Distribution Deal
23d ago
Kane Biotech Announces Distribution Agreement with Qatar Datamation Systems for revyve™ Antimicrobial Wound Gel
Premium
Press Releases
Kane Biotech Announces Distribution Agreement with Qatar Datamation Systems for revyve™ Antimicrobial Wound Gel
23d ago
Kane Biotech Receives Funding Support to Expand the revyve™ Antimicrobial Wound Gel Family
PremiumPress ReleasesKane Biotech Receives Funding Support to Expand the revyve™ Antimicrobial Wound Gel Family
1M ago
Kane Biotech Enhances revyve™ Wound Care Line
Premium
Company Announcements
Kane Biotech Enhances revyve™ Wound Care Line
2M ago
Kane Biotech Receives FDA Approval to Increase Dosage Allowance of its revyve™ Antimicrobial Wound Gel
Premium
Press Releases
Kane Biotech Receives FDA Approval to Increase Dosage Allowance of its revyve™ Antimicrobial Wound Gel
2M ago
Kane Biotech Signs Worldwide License Agreement with Omni Bioceutical Innovations Inc.
PremiumPress ReleasesKane Biotech Signs Worldwide License Agreement with Omni Bioceutical Innovations Inc.
2M ago
Kane Biotech’s First Commercial Sale of revyve™
Premium
Company Announcements
Kane Biotech’s First Commercial Sale of revyve™
3M ago
Kane Biotech Makes First Commercial Sale of revyve™ Antimicrobial Wound Gel to ProgenaCare Global
Premium
Press Releases
Kane Biotech Makes First Commercial Sale of revyve™ Antimicrobial Wound Gel to ProgenaCare Global
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100